Large-scale testing (Phase 3)Study completedNCT01575561
What this trial is testing
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Who this might be right for
Bipolar I Disorder
Sumitomo Pharma America, Inc. 377